Opiant Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Opiant Pharmaceuticals

Access the complete profile.

Opiant Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	812 Personal & Laundry Services
Address	233 Wilshire Blvd Ste 280 Santa Monica, CA 90401

Note: Revenues for privately held companies are statistical evaluations.


Opiant Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Opiant Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Opiant Pharmaceuticals is classified as operating in the Personal & Laundry Services industry, NAICS Code 812.

Opiant Pharmaceuticals Annual Revenue and Growth Rate

Opiant Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Opiant Pharmaceuticals's revenues are gauged from an analysis of company filings.

Opiant Pharmaceuticals's Income Statement (based on Industry Averages)

Opiant Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Opiant Pharmaceuticals is developing and marketing. Opiant Pharmaceuticals doesn't have any recent trademark applications, indicating Opiant Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
OPVEE Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparation, namely, an opioid antagonist	09/23/2021
REVZYP Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; Pharmaceutical preparation, namely, an opioid antagonist	02/28/2020
REVEX Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; Pharmaceutical preparation, namely, an opioid antagonist	07/13/2018

See all trademarks and details in the Full Report.

Market Share of Opiant Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Opiant Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
CINTAS	Mason, OH	100
UPBOUND GROUP	Plano, TX	85
DENTAL EXPRESS STAFFING	Wilton, WI	59
SCI SHARED RESOURCES	Houston, TX	53
TEAM PUBLIC CHOICES	San Diego, CA	50
UNIFIRST	Richmond, VA	47
TRION SOLUTIONS	Troy, MI	45
SERVICE CORPORATION INTERNATIONAL	Houston, TX	40
PLUS COMPANY U.S.	San Francisco, CA	33

Nearby Competitors

These companies are similar in business line and location to Opiant Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
YOGAWORKS	Santa Monica, CA	100
BARK & BIRCH	Santa Monica, CA	17
OPIANT PHARMACEUTICALS	Santa Monica, CA	13
GLOVEWORX USA	Santa Monica, CA	8
FITDOG SPORTS CLUB	Santa Monica, CA	5
CONFIRMED	Santa Monica, CA	4

Future Competition: Opiant Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Opiant Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)